What is the half-life of intravenous (IV) metoprolol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Half-Life of Intravenous Metoprolol

The elimination half-life of intravenous metoprolol is 3 to 4 hours in most patients (extensive CYP2D6 metabolizers), but may be prolonged to 7 to 9 hours in poor CYP2D6 metabolizers. 1

Pharmacokinetic Details

The FDA-approved drug label provides the definitive pharmacokinetic parameters for IV metoprolol:

  • Standard elimination half-life: 3-4 hours in patients with normal CYP2D6 metabolism (extensive metabolizers), who represent approximately 92% of Caucasians and 98% of most other populations 1

  • Prolonged half-life: 7-9 hours in poor CYP2D6 metabolizers, who comprise about 8% of Caucasians and 2% of most other populations 1

  • Distribution half-life: 5-30 minutes, indicating rapid tissue distribution after IV administration 2

Clinical Implications of Half-Life

The relatively short half-life of IV metoprolol has important clinical consequences:

  • Maximum beta-blockade is achieved at approximately 20 minutes after IV infusion over a 10-minute period 1

  • Less than 10% of an IV dose is excreted unchanged in urine in extensive metabolizers, while up to 40% may be excreted unchanged in poor metabolizers 1

  • The short half-life necessitates transition to oral therapy within 15 minutes after the last IV dose to maintain therapeutic effect, typically starting with 25-50 mg orally every 6 hours 3

Factors Affecting Half-Life

Several patient-specific factors can alter metoprolol's elimination half-life:

  • Hepatic impairment significantly prolongs half-life up to 7.2 hours depending on severity, since the drug is primarily eliminated by hepatic metabolism 1

  • Renal impairment does not clinically affect half-life in a significant way, as systemic availability and half-life in patients with renal failure do not differ meaningfully from normal subjects 1

  • Geriatric patients may show slightly higher plasma concentrations due to decreased hepatic metabolism and blood flow, though this is not clinically significant for half-life 1

Comparison with Other Beta-Blockers

Research data from extracorporeal treatment studies provides comparative context:

  • Metoprolol's half-life during hemodialysis was 2.9 hours (with metabolite half-life of 5 hours), consistent with the FDA label 4

  • This is shorter than atenolol (HD half-life 4.6 hours) but longer than esmolol (HD half-life 0.12 hours) 4

  • Historical pharmacokinetic studies from the 1970s-1980s confirmed the 3-4 hour elimination half-life range in various patient populations 5, 2, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.